Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Latest News

News Review
VIDEO: Dr. Antoni Ribas Talks Secondary Skin Cancers with BRAF Inhibitor Zelboraf and How They Can Be Prevented
Posted Date: 2/7/2012 10:45 AM

Dr. Antoni RibasIn this 10-minute video interview, watch UCLA Jonsson Comprehensive Cancer Center scientist Dr. Antoni Ribas discuss recent research findings that are aiding in the development of new treatments for advanced squamous cell carcinoma. He also explains how MEK inhibitor drugs are now being used in clinical trials. (From CurrentMedicine.tv)

Watch the video.

 

Save/Share
Mixx Google Digg Reddit Facebook Yahoo! Newsvine MySpace